About Urology Group of New Mexico
Clinical Trials at Urology Group of New Mexico
During the past decade, Urology Group of New Mexico conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Urology Group of New Mexico" #1 sponsor was "AEterna Zentaris" with 1 trials, followed by "Active Biotech AB" with 1 trials
sponsored, "Bavarian Nordic" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "GTx"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Urology Group of New Mexico"
#1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "Therion Biologics Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Urology Group of New Mexico
According to Clinical.Site data, the most researched conditions in "Urology Group of New Mexico" are
"Prostate Cancer" (4 trials), "Benign Prostatic Hypertrophy" (1 trials), "Bladder Cancer" (1 trials), "Fractures" (1 trials) and "Osteoporosis" (1 trials). Many other conditions were trialed in "Urology Group of New Mexico" in a lesser frequency.
Clinical Trials Intervention Types at Urology Group of New Mexico
Most popular intervention types in "Urology Group of New Mexico" are "Drug" (7 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "ABR-215050, tasquinimod" (1 trials), "Apaziquone" (1 trials), "Auriclosene Irrigation Solution, 0.2%" (1 trials) and "Auriclosene Vehicle Solution" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Urology Group of New Mexico
The vast majority of trials in "Urology Group of New Mexico" are
6 trials for "Male" genders and 2 trials for "All" genders.
Clinical Trials Status at Urology Group of New Mexico
Currently, there are NaN active trials in "Urology Group of New Mexico".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Urology Group of New Mexico,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Urology Group of New Mexico, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Urology Group of New Mexico
Urology Group of New Mexico has several departments that took part in Clinical trials: "AccumetRx Clinical Research - Division of Urology Group of New Mexico" - 2 trials